Aura Biosciences Presents Preclinical Data Highlighting AU-011’s Anti-Tumor Activity in Choroidal Metastasis, an Additional Ocular Oncology Indication at the 2022 ARVO Annual Meeting - Arix Bioscience

Close Navigation

About Strategy Team Portfolio Insights Media Contact

Overlay

Aura Biosciences Presents Preclinical Data Highlighting AU-011’s Anti-Tumor Activity in Choroidal Metastasis, an Additional Ocular Oncology Indication at the 2022 ARVO Annual Meeting

3rd May 2022

Portfolio

This post references, or is about Aura. Find out more by clicking below

Video

Cambridge, USA

Useful Tools

Download, print or share this article

Print

Print Article Email

Email

Print

Share Article